Prednisolone prescribing practices for dogs in Australia

Although prednisolone is a routinely prescribed medication in dogs, there is a lack of information regarding prednisolone prescribing practices by veterinarians. This study aims to describe characteristics of dogs receiving prednisolone, disease processes treated, doses prescribed as well as to iden...

Full description

Bibliographic Details
Main Authors: Bonnie Purcell, Anke Wiethoelter, Julien Dandrieux
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974108/?tool=EBI
_version_ 1811160742578094080
author Bonnie Purcell
Anke Wiethoelter
Julien Dandrieux
author_facet Bonnie Purcell
Anke Wiethoelter
Julien Dandrieux
author_sort Bonnie Purcell
collection DOAJ
description Although prednisolone is a routinely prescribed medication in dogs, there is a lack of information regarding prednisolone prescribing practices by veterinarians. This study aims to describe characteristics of dogs receiving prednisolone, disease processes treated, doses prescribed as well as to identify factors influencing the dose rate in Australia. The VetCompass Australia database was queried to identify dogs prescribed prednisolone between 1 July 2016 to 31 July 2018 (inclusive). A random sample of 2,000 dogs from this population were selected. Dog demographic data, prednisolone dose and indication for prescription were collated. Indicated dose for the condition treated was compared to prescribed dose. Multivariable linear regression was used to identify patient-level characteristics associated with prescribed prednisolone dose. A large and small breed dog cohort, treated for the same disease process, were compared for differences in dosing. Median age of dogs was 73 (range 2 to 247) months and median body weight was 17 (range 1.56 to 90) kg. Median prescribed prednisolone dose was 0.8 mg/kg/day, with most dogs receiving an anti-inflammatory dose (0.3–1 mg/kg/day, 58%). Prednisolone prescriptions were predominantly for diseases of the integument (n = 1645, 82%) followed by unknown indication and respiratory disease. A total of 152 dogs (8%) were prescribed immunosuppressive doses of prednisolone for conditions where an anti-inflammatory dose would be recommended. Increases in bodyweight were associated with lower doses on mg/kg scale but higher doses on a mg/m2 scale (p < 0.001). Overall, prednisolone was primarily used as an anti-inflammatory in this population, with some inappropriate use of immunosuppressive doses. Increasing bodyweight was associated with a small reduction in dose in mg/kg, suggesting that clinicians are adjusting prednisolone dose rates based on dog bodyweight.
first_indexed 2024-04-10T06:02:36Z
format Article
id doaj.art-4fedd11fd8d24f96b88fc007dc71d7a1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T06:02:36Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4fedd11fd8d24f96b88fc007dc71d7a12023-03-03T05:31:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01182Prednisolone prescribing practices for dogs in AustraliaBonnie PurcellAnke WiethoelterJulien DandrieuxAlthough prednisolone is a routinely prescribed medication in dogs, there is a lack of information regarding prednisolone prescribing practices by veterinarians. This study aims to describe characteristics of dogs receiving prednisolone, disease processes treated, doses prescribed as well as to identify factors influencing the dose rate in Australia. The VetCompass Australia database was queried to identify dogs prescribed prednisolone between 1 July 2016 to 31 July 2018 (inclusive). A random sample of 2,000 dogs from this population were selected. Dog demographic data, prednisolone dose and indication for prescription were collated. Indicated dose for the condition treated was compared to prescribed dose. Multivariable linear regression was used to identify patient-level characteristics associated with prescribed prednisolone dose. A large and small breed dog cohort, treated for the same disease process, were compared for differences in dosing. Median age of dogs was 73 (range 2 to 247) months and median body weight was 17 (range 1.56 to 90) kg. Median prescribed prednisolone dose was 0.8 mg/kg/day, with most dogs receiving an anti-inflammatory dose (0.3–1 mg/kg/day, 58%). Prednisolone prescriptions were predominantly for diseases of the integument (n = 1645, 82%) followed by unknown indication and respiratory disease. A total of 152 dogs (8%) were prescribed immunosuppressive doses of prednisolone for conditions where an anti-inflammatory dose would be recommended. Increases in bodyweight were associated with lower doses on mg/kg scale but higher doses on a mg/m2 scale (p < 0.001). Overall, prednisolone was primarily used as an anti-inflammatory in this population, with some inappropriate use of immunosuppressive doses. Increasing bodyweight was associated with a small reduction in dose in mg/kg, suggesting that clinicians are adjusting prednisolone dose rates based on dog bodyweight.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974108/?tool=EBI
spellingShingle Bonnie Purcell
Anke Wiethoelter
Julien Dandrieux
Prednisolone prescribing practices for dogs in Australia
PLoS ONE
title Prednisolone prescribing practices for dogs in Australia
title_full Prednisolone prescribing practices for dogs in Australia
title_fullStr Prednisolone prescribing practices for dogs in Australia
title_full_unstemmed Prednisolone prescribing practices for dogs in Australia
title_short Prednisolone prescribing practices for dogs in Australia
title_sort prednisolone prescribing practices for dogs in australia
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974108/?tool=EBI
work_keys_str_mv AT bonniepurcell prednisoloneprescribingpracticesfordogsinaustralia
AT ankewiethoelter prednisoloneprescribingpracticesfordogsinaustralia
AT juliendandrieux prednisoloneprescribingpracticesfordogsinaustralia